Skip to content

Drug interactions

Ranolazine + Tucatinib

Severity: Contraindicated

Ranolazine and Tucatinib: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib is a strong CYP3A inhibitor and can substantially raise ranolazine concentrations. This increases QT prolongation and dose-related adverse effects.

What this interaction means in plain words

Ranolazine and Tucatinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Ranolazine belongs to Cardiovascular; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibits CYP3A4, reducing ranolazine metabolism.

What to do

Avoid the combination, since ranolazine is contraindicated with strong CYP3A inhibitors. Use an alternative antianginal during tucatinib therapy.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ranolazine and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ranolazine with Tucatinib?

MediHelp rates the interaction as contraindicated. Ranolazine and Tucatinib are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Tucatinib is a strong CYP3A inhibitor and can substantially raise ranolazine concentrations. This increases QT prolongation and dose-related adverse effects.

How serious is the interaction between Ranolazine and Tucatinib?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination, since ranolazine is contraindicated with strong CYP3A inhibitors. Use an alternative antianginal during tucatinib therapy.

What other medicines interact with Ranolazine?

MediHelp also lists interactions of Ranolazine with, for example, Adagrasib, Amobarbital, Apalutamide. The full list is on the Ranolazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in